Last updated: April 11, 2023
Sponsor: Shanghai Jiao Tong University School of Medicine
Overall Status: Active - Recruiting
Phase
4
Condition
Stress
Circulation Disorders
Vascular Diseases
Treatment
N/AClinical Study ID
NCT04931108
NAC-BPV
Ages 30-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Men or Women.
- Aged 30-65 years.
- Ambulatory systolic blood pressure ≥ 135 mmHg and/or diastolic blood pressure ≥ 85mmHg.
- Ambulatory daytime systolic blood pressure standard deviation (SD)≥13mmHg.
- Never took antihypertensive drugs.
- Signed the written consent.
Exclusion
Exclusion Criteria:
- Under antihypertensive treatments.
- Clinic systolic blood pressure ≥ 160mmHg and/or diastolic blood pressure ≥ 100mmHg.
- Contraindications to the treatment of drugs, including hypersensitivity reaction,bradycardia, asthma, etc.
- Any cardiovascular disease except hypertension.
- Suspected or confirmed secondary hypertension.
- Poor compliance.
Study Design
Total Participants: 32
Study Start date:
September 27, 2021
Estimated Completion Date:
June 30, 2023
Study Description
Connect with a study center
Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai 200025
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.